Effect of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor (PDE4i) on markers of inflammation in COPD patients
Dave Singh, Mirco Govoni, Michele Bassi, Kai Michael Beeh, Brendan Colgan, Oliver Kornmann, Brian Laeker, Henrik Watz, Germano Lucci, Silvia Geraci, Emanuele Calabro Rocco, Aida Emirova, Marie Anna Nandeuil
European Respiratory Journal Sep 2019, 54 (suppl 63) PA2044; DOI: 10.1183/13993003.congress-2019.PA2044